What is Enclomiphene?

Enclomiphene, often marketed as enclomiphene citrate, is an oral medication primarily used to treat infertility in men. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Enclomiphene is distinct from its isomer, zuclomiphene, another component of the commonly known medication, clomiphene citrate.


Enclomiphene is chemically composed of a single enantiomer of clomiphene, a nonsteroidal compound. As a result of its specific chemical structure, it binds selectively to estrogen receptors in the body, regulating hormonal activity.
This selective binding helps in stimulating the release of hormones such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in a way that can induce ovulation in women and enhance testosterone production in men.

Enclomiphene’s mechanism of action centers on its role as a selective estrogen receptor modulator (SERM) with specific effects on the hypothalamic-pituitary-gonadal axis.


Enclomiphene exerts its therapeutic effects by influencing the delicate balance of hormones within the hypothalamic-pituitary-gonadal (HPG) axis. This axis plays a central role in regulating reproductive and sexual function in both men and women.
In women, enclomiphene’s primary role is to block estrogen receptors in the hypothalamus. This inhibition leads to an increase in the secretion of gonadotropin-releasing hormone (GnRH), which, in turn, stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland.
Elevated FSH and LH levels promote ovulation and may increase the chances of fertility in women with ovulatory dysfunction.

Mechanism of Action

Boosting Testosterone Production

In men, enclomiphene’s action is particularly relevant for those with hypogonadism or low testosterone levels. Similar to its action in women, enclomiphene acts as a SERM by blocking estrogen receptors in the hypothalamus. This action reduces the inhibitory effects of estrogen on the HPG axis.

Consequently, the hypothalamus perceives lower estrogen levels and responds by increasing the production of GnRH. The elevated GnRH levels stimulate the pituitary gland to release more LH and FSH.

LH plays a pivotal role in stimulating Leydig cells, located in the testes, to produce testosterone. The increase in LH levels induced by enclomiphene may lead to a subsequent rise in testosterone production. This makes enclomiphene a potential treatment option for men with low testosterone levels, particularly when the cause is related to secondary hypogonadism or disrupted HPG axis function.

Enclomiphene finds therapeutic application in addressing conditions such as male infertility and secondary hypogonadism and potential future applications in reproductive health and hormone management.


One of the well-established therapeutic uses of enclomiphene is in treating male infertility. It can be particularly beneficial for men with suboptimal semen parameters, including low sperm count, poor sperm motility, or abnormal sperm morphology. Enclomiphene’s mechanism of action involves increasing the production of testosterone, which is crucial for developing healthy sperm.

Stimulating the release of luteinizing hormone (LH) from the pituitary gland, enclomiphene prompts the testes to produce more testosterone. This, in turn, enhances spermatogenesis, the process of sperm production.

Over time, treatment may improve semen quality, making it a valuable option for couples struggling with male-factor infertility. However, its use in male infertility should be carefully monitored, and it may not be effective for all cases, as underlying causes can vary.

Therapeutic Uses

Potential Future Applications

Enclomiphene’s therapeutic potential extends beyond its current applications. Ongoing research is exploring its use in several other areas:

  • Female Infertility: While enclomiphene is primarily used to induce ovulation in women with ovulatory dysfunction, it may help treat female infertility.
  • Hormone Replacement Therapy (HRT): Enclomiphene’s ability to modulate estrogen and testosterone levels may make it a potential option for hormone replacement therapy in both men and women, particularly for individuals seeking alternatives to traditional hormone therapies.
  • Polycystic Ovary Syndrome (PCOS): PCOS is a common condition in women with hormonal imbalances. Enclomiphene may play a role in managing the hormonal disruptions associated with PCOS and improving fertility outcomes.
  • Athletic Performance: Some athletes and bodybuilders have explored using enclomiphene to boost testosterone levels and enhance muscle growth and performance. However, this practice is often controversial and may have legal and health implications.

Administration and Dosage

Enclomiphene is typically administered orally in tablet form, with enclomiphene dosages tailored to individual patient needs and closely monitored for optimal effectiveness.


Neuromodulators such as Botox can reduce muscle movements and relax wrinkles.

The best candidates for Neuromodulators are those who are healthy and reduce the appearance of facial wrinkles.

You’ll see the complete results 14 days after treatment. You may get mild improvements within a few days.

The results are not permanent and last for 4-6 months.

We offer botox in Atlanta GA Office. We also offer botox in Lauderdale FL and botox in Tupelo MS.

Book An Appointment

Schedule a Consultation Today

Call Now Button